Recent QLGN News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 08:55:34 PM
- Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 • GlobeNewswire Inc. • 11/01/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 08:05:37 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/24/2024 09:06:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 08:35:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/17/2024 08:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 08:10:10 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/09/2024 08:10:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 09:10:13 PM
- Qualigen Therapeutics, Inc. Announces management changes. • GlobeNewswire Inc. • 09/26/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:10:16 PM
- Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel • GlobeNewswire Inc. • 09/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:15:12 PM
- Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) • GlobeNewswire Inc. • 09/06/2024 09:00:00 PM
- Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering • GlobeNewswire Inc. • 09/06/2024 08:30:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 09/06/2024 07:46:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 01:25:32 PM
- Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering • GlobeNewswire Inc. • 09/05/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/22/2024 08:41:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:06:05 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/09/2024 07:58:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2024 09:28:29 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM